Butterfli
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Butterfli - overview
Established
2022
Location
Nanjing, Jiangsu, China
Primary Industry
Packaging
About
Founded in 2022 and based in Nanjing, China, Butterfli engages in the production of advanced polymer pre-filled syringe systems. Butterfli specializes in advanced polymer pre-filled syringe systems designed to enhance the delivery of pharmaceutical products. Their core offerings include the Crystal BioPure® Luer Lock pre-filled syringes, dual-thread Luer Lock pre-filled syringes, and stack needle pre-filled syringes, all engineered to eliminate the need for silicone oil, thereby providing a more streamlined and effective solution for drug delivery. The company generates revenue through sales of their flagship Crystal BioPure® products and other related products.
The funding raised in August 2025 will be used to support the company's commercial expansion of next-generation products, accelerate international quality system certification, and expand into the global market, further enhancing its competitiveness in the high-end syringe market.
Current Investors
China Growth Capital, Jolmo Capital, TopOlefin Technology
Primary Industry
Packaging
Sub Industries
Medical Devices & Equipment, Packaging
Website
www.butterflypp.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.